The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors

J Trace Elem Med Biol. 2011 Jul;25(3):154-9. doi: 10.1016/j.jtemb.2011.04.001. Epub 2011 May 23.

Abstract

Oxidative stress induced by the combined deficiencies of selenium (Se) and vitamin E (VE) is considered the basic factor of Keshan disease (KD). Dehydroepiandrosterone (DHEA) is a naturally occurring adrenal androgen that has antioxidant properties. We found that a Se- and VE-deficient diet induced KD lesions in rats, while 0.05, 0.125, and 0.25 g/kg DHEA caused a concentration-dependent inhibition in the development of oxidative stress and extracellular matrix (ECM) deposition in the left ventricles of the Se- and VE-deficient rats. In addition, DHEA counteracted activation of NFκB as well as the subsequent increase in TGFβ-1 and CTGF induced by the Se- and VE-deficient diet. These studies suggested that DHEA prevents oxidative stress and might be useful in treating Se and VE deficiency-related KD. These effects were based on its antioxidant effects and ECM deposition inhibition in left ventricles.

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Cardiomyopathies / blood
  • Cardiomyopathies / pathology*
  • Connective Tissue Growth Factor / metabolism
  • Dehydroepiandrosterone / administration & dosage
  • Dehydroepiandrosterone / blood
  • Dehydroepiandrosterone / pharmacology*
  • Disease Models, Animal
  • Enterovirus Infections / blood
  • Enterovirus Infections / pathology*
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / metabolism
  • Fibrosis
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Immunohistochemistry
  • Myocardium / pathology*
  • Organ Size / drug effects
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects*
  • Rats
  • Rats, Wistar
  • Transcription Factor RelA / metabolism
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Transcription Factor RelA
  • Transforming Growth Factor beta1
  • Connective Tissue Growth Factor
  • Dehydroepiandrosterone

Supplementary concepts

  • Keshan disease